Stay updated on Gemini 2 Clinical Trial: DTG/3TC vs. DTG/FTC/TDF
Sign up to get notified when there's something new on the Gemini 2 Clinical Trial: DTG/3TC vs. DTG/FTC/TDF page.
Latest updates to the Gemini 2 Clinical Trial: DTG/3TC vs. DTG/FTC/TDF page
- Check7 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.0%
- Check14 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the Contacts and Locations section.SummaryDifference0.5%
- Check21 days agoChange DetectedA significant deletion has occurred, removing a detailed study on the efficacy of Dolutegravir plus Lamivudine versus Dolutegravir plus Tenofovir in HIV-1 treatment, which may impact the available research references.SummaryDifference2%
- Check29 days agoChange DetectedThe website has been updated from version v2.12.1 to v2.12.2.SummaryDifference0.0%
- Check50 days agoChange DetectedThe website has been updated from version v2.12.0 to v2.12.1.SummaryDifference0.0%
- Check58 days agoChange DetectedThe website has been updated to include the week 48 results from the GEMINI-1 and GEMINI-2 trials comparing dolutegravir plus lamivudine to dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in HIV-1 treatment, with the revision updated from v2.11.2 to v2.12.0.SummaryDifference2%
Stay in the know with updates to Gemini 2 Clinical Trial: DTG/3TC vs. DTG/FTC/TDF
Enter your email address, and we'll notify you when there's something new on the Gemini 2 Clinical Trial: DTG/3TC vs. DTG/FTC/TDF page.